Thank-you Eisai for sponsoring the Beyond the NGS Report: Practical Interpretation for Lung Cancer Care webinar. The session will provide medical oncologists with practical guidance on interpreting lung cancer molecular reports, identifying targetable alterations, and

We're back with an episode on ALK TKI sequencing in the Australian landscape. Join Prof Ben Solomon, A/Prof Tim Clay and A/Prof Malinda Itchins as they discuss treatment for this subset of NSCLC and the advances through four generations of inhibitors. Listen on Apple: buff.ly/L8TrfTn

🎧️ NEW EPISODE TOMORROW Our host A/Prof Tim Clay sits down with Australian oncology luminaries Prof Ben Solomon and A/Prof Malinda Itchins to discuss the rapidly evolving landscape of Anaplastic Lymphoma Kinase (ALK) positive lung cancer. Tune in from Friday, April 10th, at 8am.

Build confidence in interpreting lung cancer molecular reports in this focused and practical webinar. TOGA's Beyond the NGS Report: Practical Interpretation for Lung Cancer Care webinar brings together expert perspectives to help clinicians better understand lung cancer

The Preventative and Quality Care Working Group represents TOGA’s commitment to improving the outcomes of thoracic cancers. This new working group ensures TOGA has representation and efforts across every front from earlier diagnosis, fair access to high-quality care,

The 2025 Annual Report is here. Our TOGA community continues to grow. The 2025 Annual Report highlights a year of growth, engagement, and connection. Learn more > buff.ly/jycFCn7

We’re delighted to welcome Johnson & Johnson as a sponsor of the Beyond the NGS Report: Practical Interpretation for Lung Cancer Care webinar. This interactive session is designed to support medical oncologists in confidently interpreting lung cancer molecular reports,

Don’t miss this opportunity to deepen your understanding of lung cancer molecular reporting. Join us for Beyond the NGS Report: Practical Interpretation for Lung Cancer Care, a webinar designed to help you confidently interpret lung cancer molecular pathology reports in

The 2025 Annual Report is here. Education remains at the heart of what we do. For the first time in TOGA's history the ASM was held in Brisbane, bringing together 416 attendees. Thank you to all our speakers, contributors, and attendees who made the education program

TOGA’s Working Groups are evolving to better reflect where thoracic cancer research is heading: From prevention and early detection through to advanced disease and living with lung cancers. Consider joining the new working group or an existing one. Submit research concepts –

We're pleased to welcome Merck as a sponsor of the Beyond the NGS Report: Practical Interpretation for Lung Cancer Care webinar. This interactive session will support medical oncologists to interpret lung cancer molecular reports with confidence, identify actionable mutations,

Our 2025 Annual Report is out! Inside, you’ll find highlights from a year of advancing clinical trials, fostering collaboration, and supporting innovation in thoracic oncology. Thank you to everyone who has contributed to this progress. We’re excited to continue building on

The next post in our Clinical Trial Design Series is here! This instalment walks through how to turn your research concept into a clinical trial, covering key steps from sponsor selection and budgeting to safety planning and protocol development.

NGS reports can be complex but understanding what’s clinically relevant is critical for lung cancer care. This interactive webinar will equip medical oncologists with practical skills to confidently interpret lung cancer molecular reports. Participants will explore real-world

We’re accepting abstract submissions for the 2026 TOGA ASM! The LOC welcomes submissions from across the TOGA community to help shape this year’s program of presentations and discussion. We encourage you to put your work forward for a chance to be part of the meeting.

A huge thank you to everyone who joined us for the TOGA Small Cell Lung Cancer Masterclass in Melbourne last week. It was a fantastic day of learning, discussion and collaboration, bringing together clinicians to explore the rapidly evolving landscape of SCLC care.

We're delighted to welcome Prof Sara Ramella, who will be joining us at the 2026 TOGA ASM! Prof Sara Ramella is Professor of Radiation Oncology at Campus Bio-Medico University, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy. She is also a member of the

A great turnout to our SCLC Masterclass today! Always great seeing everyone in-person and learning about challenging disease areas.

How confident are you interpreting lung cancer molecular reports? Join us for Beyond the NGS Report: Practical Interpretation for Lung Cancer Care, an interactive webinar helping medical oncologists navigate NGS results and identify actionable mutations.

Introducing the first instalment in our Clinical Trial Design Series! This post explores how to get started with investigator-initiated trials, a must-read for clinicians and researchers looking to contribute to meaningful lung cancer research. Read the full article here >

Abstract submissions for the 2026 TOGA ASM are open! The LOC encourages all members of the TOGA community to submit their abstracts for consideration. Don’t miss the chance to showcase your work and be part of this year’s engaging program of discussions and presentations.

We're excited to have Prof Sanjay Popat join us at the 2026 TOGA ASM! Prof Sanjay Popat is Chair of Thoracic Oncology at The Institute of Cancer Research and Consultant Medical Oncologist at The Royal Marsden Hospital where he is Head of the Lung Unit and Head of the Lung

A huge thank you to the Rotary Club of Chatswood International and Dr Angeline Low for organising the Lunar New Year Banquet. What a fun and successful evening! Your generosity is helping TOGA continue our work in lung cancer care, supporting research, education, and

Registrations are now open for TOGA's Beyond the NGS Report: Practical Interpretation for Lung Cancer Care. This interactive webinar will help medical oncologists: - Interpret lung cancer molecular reports with confidence - Identify actionable mutations

We're thrilled to welcome A/Prof Surein Arulananda as this year's ASM Convenor! "It is my great pleasure to welcome you to the TOGA 2026 Annual Scientific Meeting. This year’s meeting themed ‘Shaping tomorrow’s thoracic cancer care together’ will showcase the latest hot topics

Tarlatamab is changing the game in SCLC. See the trial data, understand the PBS landscape, and master the clinical use. Secure your place at our Small Cell Lung Cancer Masterclass now 👉 🚨 Limited spots available. 📅 Date: March 20 ⏰ Time: 10:00AM - 4:30PM

Happy International Women’s Day! At TOGA, we recognise the invaluable contributions of women in thoracic oncology and reaffirm our commitment to gender equity across research, leadership and clinical excellence. #IWD2026 #GiveToGain

🎧 Have you listened yet? Catch up on our latest episode of Conversations in Lung Cancer Research featuring Prof Michael Millward, who reflects on how oncology care has evolved, from largely palliative treatment to a far more nuanced approach with growing expectations of

Abstract submissions are now open for the 2026 TOGA ASM. The LOC encourages everyone across the TOGA community submit abstracts for consideration in this year’s program. It’s a great chance to showcase share your research, and contribute to an exciting lineup of discussions

We’re pleased to welcome AstraZeneca as a sponsor of the Small Cell Lung Cancer Masterclass. Their support helps deliver high-quality, clinically relevant education for health professionals working in lung cancer care. 📅 Date: March 20 ⏰ Time: 10:00AM - 4:30PM

Lung cancer care in 2025 hit a turning point. Want to know what’s driving progress and what it means for patients, clinicians and the health system? Read the full breakdown here >

ASM news incoming.... The theme for the 2026 TOGA ASM is Shaping Tomorrow’s Thoracic Cancer Care Together. We can't wait to see you there. 📅 Save the date: 15-17 July 2026 📍 Location: Pullman Melbourne Albert Park Find out more >https://buff.ly/myaf07F

We’re delighted to welcome MSD as a sponsor of the Small Cell Lung Cancer Masterclass. Their support contributes to the delivery of timely, evidence-informed education for clinicians dedicated to improving outcomes in lung cancer care. 📅 Date: 20 March

In our most recent episode of Conversations in Lung Cancer, Prof Michael Millward explains how innovative approaches in lung cancer and melanoma are reshaping patient care, and why liquid biopsies are the next frontier. Listen on Apple: buff.ly/lcYtcBS

💡 Exciting news for tomorrow morning! In the latest episode of Conversations in Lung Cancer Research, A/Prof Mel Moore chats with Prof Michael Millwward shares insights from his lung cancer and melanoma research, plus practical advice for young oncologists wanting to combine

From evidence to the clinic, Tarlatamab in practice. At our upcoming SCLC Masterclass, A/Prof Sagun Parakh will present a focused ES-SCLC case study, exploring the real-world application of Tarlatamab and key considerations for patient management. Limited spots available.

Prof Nick Pavlakis discusses the evolving treatment landscape in 2025 in TOGA's Lung Cancer Research: 2025 Year in Review podcast episode. Listen on Apple: buff.ly/MYzS7VI Spotify: buff.ly/Gs3mt6f Read show notes: buff.ly/3Vh7WKQ

🌍 International insight. Emerging evidence. New directions in SCLC. As part of our upcoming Small Cell Lung Cancer Masterclass, Dr Maurice Pérol will share an international perspective on progress in the small cell space

We’re grateful to have Amgen on board as a sponsor of the Small Cell Lung Cancer Masterclass. Their commitment to advancing care in lung cancer is instrumental in supporting meaningful, clinician-focused education. 📅 Date: March 20 ⏰ Time: 10:00AM - 4:30PM

In the latest episode of Conversations in Lung Cancer Research, Dr Megan Sanders explores why lung cancer is one of the most dynamic spaces in oncology. Tune in to the latest episode. Listen on Apple: buff.ly/ERH7lIB Spotify: buff.ly/lBxwTen Read show notes: buff.ly/4qcnVr0

Understanding EGFR-positive lung cancer in Asian populations matters, and so does supporting the research behind it. Our latest blog explores why EGFR mutations are more common in Asian populations and how advances in targeted therapies are improving outcomes.

Managing CRS and ICANS in the era of emerging SCLC therapies is critical. At our SCLC Masterclass, A/Prof Surein Arulananda will guide clinicians through practical strategies for recognising, preventing, and managing CRS/ICANS, helping translate trial experience into

Multidisciplinary engagement has strengthened the sector, and patients are better for it. Listen to the full conversation now. Listen on Apple: buff.ly/gVRSfNN Spotify: buff.ly/lBxwTen Read show notes: buff.ly/4qcnVr0

Out now! A/Prof Mel Moore sits down with Dr Megan Sanders, CEO of TOGA, to discuss her journey from vaccine research to leading one of Australia’s key thoracic oncology organisations. Don’t miss this insightful conversation. Listen on Apple: buff.ly/L5gh1SU

🚨 Secure your spot and save! The Small Cell Lung Cancer Masterclass is your chance to explore the latest advances in SCLC treatment and gain practical insights to apply in your practice. ⏳ Early bird registration closes 16 February 📅 Date: 20 March

On International Day of Women and Girls in Science, we celebrate the women shaping the future of lung cancer research and treatment. Their dedication expands knowledge, improves care, and inspires the next generation of scientists. Together we break barriers and

Join the Rotary Club of Chatswood International and lung cancer survivor Dr Angeline Low as we come together to support TOGA and fuel vital research that leads to earlier detection, better treatments, and brighter futures. Be part of an unforgettable evening. Your ticket

The SCLC landscape is shifting. Don't miss our expert-led masterclass on Tarlatamab, from trial outcomes to practical PBS application. 🚨 Early bird registration closes in 1 week. 📅 Date: March 20 ⏰ Time: 10:00AM - 4:30PM 📍 Location: Novotel Melbourne on Collins

We’re proud to welcome Roche as a sponsor of the Small Cell Lung Cancer Masterclass. Roche’s long-standing dedication to improving outcomes in lung cancer care helps make this important educational event possible. 📅 Date: 20 March ⏰ Time: 10:00 am – 4:30 pm

Lung cancer remains one of the leading causes of cancer-related death in Australia yet stigma and underfunding persist. On World Cancer Day, TOGA stands with patients, families, and clinicians to advocate for greater awareness, research, and progress in lung cancer care.